Stock Earnings

Question 1

Quels sont les états financiers clés de Sangamo Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Sangamo Therapeutics Inc a un total d'actifs de $101, un bénéfice net loss de $-97

Question 2

Quels sont les ratios financiers clés pour SGMO ?

Accepted Answer

Le ratio de liquidité de Sangamo Therapeutics Inc est 1.29, la marge nette est -170.17, les ventes par action sont de $0.28.

Question 3

Comment les revenus de Sangamo Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Sangamo Therapeutics Inc largest revenue segment is Zinc Finger Protein, at a revenue of 176,232,000 in the most earnings release.For geography, United States is the primary market for Sangamo Therapeutics Inc, at a revenue of 176,232,000.

Question 4

Sangamo Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Sangamo Therapeutics Inc a un bénéfice net loss de $-97

Question 5

Sangamo Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Sangamo Therapeutics Inc a un passif de 78

Question 6

Combien d'actions en circulation Sangamo Therapeutics Inc a-t-elle ?

Accepted Answer

Sangamo Therapeutics Inc a un total d'actions en circulation de 212.83

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	32	57	176	111	110	118
Revenue Growth (YoY)	-38%	-68%	59%	1%	-7%	16%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	36	44	57	62	63	67
Research & Development	104	111	221	249	230	180
Operating Expenses	141	155	278	312	294	247
Other Non Operating Income (Expenses)	-3	--	--	--	--	--
Pretax Income	-109	-98	-262	-191	-178	-120
Income Tax Expense	0	0	-5	0	0	0
Net Income	-108	-97	-257	-192	-178	-121
Net Income Growth	-41%	-62%	34%	8%	47%	27%
Shares Outstanding (Diluted)	304.26	201.69	174.44	154.3	144.6	134.4
Shares Change (YoY)	42%	16%	13%	7%	8%	20%
EPS (Diluted)	-0.35	-0.48	-1.47	-1.25	-1.23	-0.9
EPS Growth	-59%	-67%	18%	2%	37%	6%
Free Cash Flow	-76	-67	-245	-243	-256	155
Free Cash Flow Per Share	-0.24	-0.33	-1.4	-1.57	-1.77	1.15
Gross Margin	--	--	--	--	--	--
Operating Margin	-340.62%	-171.92%	-57.95%	-181.08%	-166.36%	-109.32%
Profit Margin	-337.5%	-170.17%	-146.02%	-172.97%	-161.81%	-102.54%
Free Cash Flow Margin	-237.5%	-117.54%	-139.2%	-218.91%	-232.72%	131.35%
EBITDA	-105	-93	-87	-189	-174	-124
EBITDA Margin	-328.12%	-163.15%	-49.43%	-170.27%	-158.18%	-105.08%
D&A For EBITDA	4	5	15	12	9	5
EBIT	-109	-98	-102	-201	-183	-129
EBIT Margin	-340.62%	-171.92%	-57.95%	-181.08%	-166.36%	-109.32%
Effective Tax Rate	0%	0%	1.9%	0%	0%	0%

Sangamo Therapeutics Inc (SGMO) Price

SGMO Stock Price Chart

SGMO Income

Follow-Up Questions